Sistema de patentes e direito à saúde: uma análise do acesso a medicamentos no caso da doença negligenciada sífilis em um contexto de saúde global

Detalhes bibliográficos
Autor(a) principal: Rocha, Nathália Facco
Data de Publicação: 2019
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Manancial - Repositório Digital da UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/21511
Resumo: The present study aimed to investigate the relationship between the right to health and access to medicines, based on the current patent system. This purpose was due to the moment when a real crisis is revealed by the lack of supply of penicillin, an antibiotic used in the treatment of such infections. Initially the study was aimed at verifying the theoretical conceptual framework concerning the right to health from its conception as a fundamental human right as well as its relation with the patent institute, since the perspective of access to medicines. The fact that generates this crisis that so severely affects the treatment of syphilis is largely attributed to international agreements and treaties in which the right to patents is conferred on the pharmaceutical industries that, by monopolizing the market, place the collective interest in a situation of vulnerability. This is compounded by the effects of the process of globalization, which favors the rapid spread of diseases, requiring that prophylactic and treatment measures be adopted to deal with those affected. In this scenario, the State has been silent and does not fulfill its service function with regard to the supply of medicines. At the end of the exclusive right of use by the expiration of the term or by the patent infringement, the public domain becomes a discouragement for the pharmaceutical industry, especially when the product to be produced does not represent a prospect of earning the intended profits, such as is the case of penicillin. In view of such a framework, the study aimed to answer the following question: to what extent is the right to health, understood in this research as the right of access to medicines for the treatment of neglected disease Syphilis, finds an obstacle in the current normative model in which the patent system is structured? The study concluded that the patent system, anchored in international laws and agreements, is at the service of the large pharmaceutical corporations and, therefore, dissociates itself from its greater purpose of promoting development and effecting the social function of industrial property. It was also realized that measures, such as public policies aimed at accompanying the transition process between exclusive exploitation with high pricing and changing status of the drug when falling into the public domain could, supposedly, minimize the current scenario of neglected diseases, such as Syphilis. To do so, the research was based on the systemic-complex theory and, in a macro sense, on the method of deductive approach and on the monographic and structuralist procedures, and bibliographic and documentary analysis was applied as technique. Thus, this dissertation is integrally inserted in the Concentration Area of the postgraduate program from University Federal de Santa Maria (UFSM) called “Emerging Rights in the Global Society”, as well as in the research line of “Socio-biodiversity Rights and Sustainability: development and dimensions of sustainability.
id UFSM_4f849cbe602ca3b3d328d5e7c5451939
oai_identifier_str oai:repositorio.ufsm.br:1/21511
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Sistema de patentes e direito à saúde: uma análise do acesso a medicamentos no caso da doença negligenciada sífilis em um contexto de saúde globalPatent system and the right to health: an analysis of access to medicines in the case of syphilis neglected disease in a global health contextMedicamentosSaúdeSífilisSistema de patentesSustentabilidadeMedicinesHealthSyphilisPatent systemSustainabilityCNPQ::CIENCIAS SOCIAIS APLICADAS::DIREITOThe present study aimed to investigate the relationship between the right to health and access to medicines, based on the current patent system. This purpose was due to the moment when a real crisis is revealed by the lack of supply of penicillin, an antibiotic used in the treatment of such infections. Initially the study was aimed at verifying the theoretical conceptual framework concerning the right to health from its conception as a fundamental human right as well as its relation with the patent institute, since the perspective of access to medicines. The fact that generates this crisis that so severely affects the treatment of syphilis is largely attributed to international agreements and treaties in which the right to patents is conferred on the pharmaceutical industries that, by monopolizing the market, place the collective interest in a situation of vulnerability. This is compounded by the effects of the process of globalization, which favors the rapid spread of diseases, requiring that prophylactic and treatment measures be adopted to deal with those affected. In this scenario, the State has been silent and does not fulfill its service function with regard to the supply of medicines. At the end of the exclusive right of use by the expiration of the term or by the patent infringement, the public domain becomes a discouragement for the pharmaceutical industry, especially when the product to be produced does not represent a prospect of earning the intended profits, such as is the case of penicillin. In view of such a framework, the study aimed to answer the following question: to what extent is the right to health, understood in this research as the right of access to medicines for the treatment of neglected disease Syphilis, finds an obstacle in the current normative model in which the patent system is structured? The study concluded that the patent system, anchored in international laws and agreements, is at the service of the large pharmaceutical corporations and, therefore, dissociates itself from its greater purpose of promoting development and effecting the social function of industrial property. It was also realized that measures, such as public policies aimed at accompanying the transition process between exclusive exploitation with high pricing and changing status of the drug when falling into the public domain could, supposedly, minimize the current scenario of neglected diseases, such as Syphilis. To do so, the research was based on the systemic-complex theory and, in a macro sense, on the method of deductive approach and on the monographic and structuralist procedures, and bibliographic and documentary analysis was applied as technique. Thus, this dissertation is integrally inserted in the Concentration Area of the postgraduate program from University Federal de Santa Maria (UFSM) called “Emerging Rights in the Global Society”, as well as in the research line of “Socio-biodiversity Rights and Sustainability: development and dimensions of sustainability.O presente estudo objetivou investigar a relação existente entre o direito à saúde e o acesso a medicamentos, a partir do que preconiza o atual sistema de patentes. Tal propósito se deu em razão do momento em que se evidencia uma verdadeira crise retratada pelo desabastecimento da penicilina, antibiótico utilizado no tratamento de tais infecções. Inicialmente, o estudo destinou-se a verificar o marco teórico conceitual relativamente ao direito à saúde desde sua concepção como direito humano fundamental, bem como sua relação com o instituto das patentes, a partir da perspectiva do acesso aos medicamentos. O fato gerador desta crise que atinge tão severamente o tratamento da sífilis, se atribui, em grande parte, aos acordos e tratados internacionais, nos quais a titularidade do direito de patentes é conferida às indústrias farmacêuticas que, ao monopolizarem o mercado, colocam em total situação de vulnerabilidade o interesse coletivo. Aliam-se a isso os efeitos produzidos pelo processo de globalização, que favorece a propagação rápida de doenças, exigindo que medidas profiláticas e de tratamento sejam adotados, a fim de contemplar os atingidos. Neste cenário, o Estado tem sido omisso e não cumpre a sua função prestacional no que tange ao fornecimento de medicamentos. Ao término do direito exclusivo de uso pelo decurso do prazo ou na ocorrência de quebra da patente, o domínio público passa a significar um desestimulo para a indústria farmacêutica, especialmente quando o medicamento a ser produzido não representa uma perspectiva de auferir os lucros almejados, como é o caso da penicilina. Diante de tal quadro, o estudo visou responder ao seguinte questionamento: em que medida o direito à saúde, compreendido nesta pesquisa como o direito de acesso a medicamentos para o tratamento da doença negligenciada Sífilis, encontra obstáculo no atual modelo normativo em que se mostra estruturado o sistema de patentes? O estudo concluiu que o sistema de patentes, ancorado em normas e acordos internacionais, está a serviço das grandes corporações farmacêuticas e, com isso, desvincula-se de seu proposito maior de promover o desenvolvimento e efetivar a função social da propriedade industrial. Percebeu-se, ainda, que medidas como políticas públicas destinadas a acompanhar o processo de transição entre a exploração exclusiva com alta precificação e a mudança de status do medicamento ao cair em domínio público poderiam, supostamente, minimizar o atual cenário das doenças negligenciadas, como, atualmente, encontra-se a Sífilis. Para tanto, a pesquisa utilizou-se da teoria da base sistêmico-complexa e, em sentido macro, do método de abordagem dedutivo e de procedimento o monográfico e estruturalista, tendo sido aplicada como técnica a análise bibliográfica e documental. Deste modo, a presente dissertação encontra-se integralmente inserida na Área de Concentração do Programa de Pós-Graduação da Universidade Federal de Santa Maria (UFSM) denominada de “Direitos Emergentes na Sociedade Global”, assim como na linha de pesquisa “Direitos da Sociobiodiversidade e Sustentabilidade: desenvolvimento e dimensões da sustentabilidade”.Universidade Federal de Santa MariaBrasilDireitoUFSMPrograma de Pós-Graduação em DireitoCentro de Ciências Sociais e HumanasGregori, Isabel Christine Silva dehttp://lattes.cnpq.br/3613134514590708Sturza, Janaína MachadoNedel, Nathalie KuczuraRocha, Nathália Facco2021-07-15T20:20:10Z2021-07-15T20:20:10Z2019-08-08info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://repositorio.ufsm.br/handle/1/21511porAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2024-04-19T13:27:43Zoai:repositorio.ufsm.br:1/21511Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2024-04-19T13:27:43Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Sistema de patentes e direito à saúde: uma análise do acesso a medicamentos no caso da doença negligenciada sífilis em um contexto de saúde global
Patent system and the right to health: an analysis of access to medicines in the case of syphilis neglected disease in a global health context
title Sistema de patentes e direito à saúde: uma análise do acesso a medicamentos no caso da doença negligenciada sífilis em um contexto de saúde global
spellingShingle Sistema de patentes e direito à saúde: uma análise do acesso a medicamentos no caso da doença negligenciada sífilis em um contexto de saúde global
Rocha, Nathália Facco
Medicamentos
Saúde
Sífilis
Sistema de patentes
Sustentabilidade
Medicines
Health
Syphilis
Patent system
Sustainability
CNPQ::CIENCIAS SOCIAIS APLICADAS::DIREITO
title_short Sistema de patentes e direito à saúde: uma análise do acesso a medicamentos no caso da doença negligenciada sífilis em um contexto de saúde global
title_full Sistema de patentes e direito à saúde: uma análise do acesso a medicamentos no caso da doença negligenciada sífilis em um contexto de saúde global
title_fullStr Sistema de patentes e direito à saúde: uma análise do acesso a medicamentos no caso da doença negligenciada sífilis em um contexto de saúde global
title_full_unstemmed Sistema de patentes e direito à saúde: uma análise do acesso a medicamentos no caso da doença negligenciada sífilis em um contexto de saúde global
title_sort Sistema de patentes e direito à saúde: uma análise do acesso a medicamentos no caso da doença negligenciada sífilis em um contexto de saúde global
author Rocha, Nathália Facco
author_facet Rocha, Nathália Facco
author_role author
dc.contributor.none.fl_str_mv Gregori, Isabel Christine Silva de
http://lattes.cnpq.br/3613134514590708
Sturza, Janaína Machado
Nedel, Nathalie Kuczura
dc.contributor.author.fl_str_mv Rocha, Nathália Facco
dc.subject.por.fl_str_mv Medicamentos
Saúde
Sífilis
Sistema de patentes
Sustentabilidade
Medicines
Health
Syphilis
Patent system
Sustainability
CNPQ::CIENCIAS SOCIAIS APLICADAS::DIREITO
topic Medicamentos
Saúde
Sífilis
Sistema de patentes
Sustentabilidade
Medicines
Health
Syphilis
Patent system
Sustainability
CNPQ::CIENCIAS SOCIAIS APLICADAS::DIREITO
description The present study aimed to investigate the relationship between the right to health and access to medicines, based on the current patent system. This purpose was due to the moment when a real crisis is revealed by the lack of supply of penicillin, an antibiotic used in the treatment of such infections. Initially the study was aimed at verifying the theoretical conceptual framework concerning the right to health from its conception as a fundamental human right as well as its relation with the patent institute, since the perspective of access to medicines. The fact that generates this crisis that so severely affects the treatment of syphilis is largely attributed to international agreements and treaties in which the right to patents is conferred on the pharmaceutical industries that, by monopolizing the market, place the collective interest in a situation of vulnerability. This is compounded by the effects of the process of globalization, which favors the rapid spread of diseases, requiring that prophylactic and treatment measures be adopted to deal with those affected. In this scenario, the State has been silent and does not fulfill its service function with regard to the supply of medicines. At the end of the exclusive right of use by the expiration of the term or by the patent infringement, the public domain becomes a discouragement for the pharmaceutical industry, especially when the product to be produced does not represent a prospect of earning the intended profits, such as is the case of penicillin. In view of such a framework, the study aimed to answer the following question: to what extent is the right to health, understood in this research as the right of access to medicines for the treatment of neglected disease Syphilis, finds an obstacle in the current normative model in which the patent system is structured? The study concluded that the patent system, anchored in international laws and agreements, is at the service of the large pharmaceutical corporations and, therefore, dissociates itself from its greater purpose of promoting development and effecting the social function of industrial property. It was also realized that measures, such as public policies aimed at accompanying the transition process between exclusive exploitation with high pricing and changing status of the drug when falling into the public domain could, supposedly, minimize the current scenario of neglected diseases, such as Syphilis. To do so, the research was based on the systemic-complex theory and, in a macro sense, on the method of deductive approach and on the monographic and structuralist procedures, and bibliographic and documentary analysis was applied as technique. Thus, this dissertation is integrally inserted in the Concentration Area of the postgraduate program from University Federal de Santa Maria (UFSM) called “Emerging Rights in the Global Society”, as well as in the research line of “Socio-biodiversity Rights and Sustainability: development and dimensions of sustainability.
publishDate 2019
dc.date.none.fl_str_mv 2019-08-08
2021-07-15T20:20:10Z
2021-07-15T20:20:10Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/21511
url http://repositorio.ufsm.br/handle/1/21511
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Direito
UFSM
Programa de Pós-Graduação em Direito
Centro de Ciências Sociais e Humanas
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Direito
UFSM
Programa de Pós-Graduação em Direito
Centro de Ciências Sociais e Humanas
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1805922136122982400